User profiles for Cathrine Axfors
 | Cathrine AxforsPostdoctoral Fellow, Meta-research Innovation Center at Stanford (METRICS), Stanford … Verified email at stanford.edu Cited by 1917 |
[HTML][HTML] Population-level COVID-19 mortality risk for non-elderly individuals overall and for non-elderly individuals without underlying diseases in pandemic …
JPA Ioannidis, C Axfors… - Environmental research, 2020 - Elsevier
Objective To provide estimates of the relative rate of COVID-19 death in people <65 years
old versus older individuals in the general population, the absolute risk of COVID-19 death at …
old versus older individuals in the general population, the absolute risk of COVID-19 death at …
Mortality outcomes with hydroxychloroquine and chloroquine in COVID-19 from an international collaborative meta-analysis of randomized trials
Substantial COVID-19 research investment has been allocated to randomized clinical trials (RCTs)
on hydroxychloroquine/chloroquine, which currently face recruitment challenges or …
on hydroxychloroquine/chloroquine, which currently face recruitment challenges or …
[HTML][HTML] Association of convalescent plasma treatment with clinical outcomes in patients with COVID-19: a systematic review and meta-analysis
Importance Convalescent plasma is a proposed treatment for COVID-19. Objective To assess
clinical outcomes with convalescent plasma treatment vs placebo or standard of care in …
clinical outcomes with convalescent plasma treatment vs placebo or standard of care in …
Association between convalescent plasma treatment and mortality in COVID-19: a collaborative systematic review and meta-analysis of randomized clinical trials
Background Convalescent plasma has been widely used to treat COVID-19 and is under
investigation in numerous randomized clinical trials, but results are publicly available only for a …
investigation in numerous randomized clinical trials, but results are publicly available only for a …
Infection fatality rate of COVID-19 in community-dwelling elderly populations
C Axfors, JPA Ioannidis - European Journal of Epidemiology, 2022 - Springer
This mixed design synthesis aimed to estimate the infection fatality rate (IFR) of Coronavirus
Disease 2019 (COVID-19) in community-dwelling elderly populations and other age groups …
Disease 2019 (COVID-19) in community-dwelling elderly populations and other age groups …
Age-stratified infection fatality rate of COVID-19 in the non-elderly population
… Cathrine Axfors has received funding outside this work from the Knut and Alice Wallenberg
Foundation's Postdoctoral Fellowship (KAW, 2019.0561) and postdoctoral grants from …
Foundation's Postdoctoral Fellowship (KAW, 2019.0561) and postdoctoral grants from …
Second versus first wave of COVID-19 deaths: shifts in age distribution and in nursing home fatalities
JPA Ioannidis, C Axfors… - Environmental research, 2021 - Elsevier
Objective To examine whether the age distribution of COVID-19 deaths and the share of
deaths in nursing homes changed in the second versus the first pandemic wave. Eligible data …
deaths in nursing homes changed in the second versus the first pandemic wave. Eligible data …
Characteristics of women with different perinatal depression trajectories
A Wikman, C Axfors, SI Iliadis, J Cox… - Journal of …, 2020 - Wiley Online Library
Maternal perinatal depression (PND), a common mental disorder with a prevalence of over
10%, is associated with long‐term health risks for both mothers and offspring. This study …
10%, is associated with long‐term health risks for both mothers and offspring. This study …
Change in age distribution of COVID-19 deaths with the introduction of COVID-19 vaccination
Objectives Most countries initially deployed COVID-19 vaccines preferentially in elderly
populations. We aimed to evaluate whether population-level vaccine effectiveness is heralded …
populations. We aimed to evaluate whether population-level vaccine effectiveness is heralded …
[HTML][HTML] The worldwide clinical trial research response to the COVID-19 pandemic-the first 100 days
Background: Never before have clinical trials drawn as much public attention as those
testing interventions for COVID-19. We aimed to describe the worldwide COVID-19 clinical …
testing interventions for COVID-19. We aimed to describe the worldwide COVID-19 clinical …
